Metabolic rearrangements and intratumoral heterogeneity for immune response in hepatocellular carcinoma
Liver cancer is one of the most common malignant tumors globally. Not only is it difficult to diagnose, but treatments are scarce and the prognosis is generally poor. Hepatocellular carcinoma (HCC) is the most common type of liver cancer. Aggressive cancer cells, such as those found in HCC, undergo...
Main Authors: | Fei-Qi Xu, Meng-Meng Dong, Zhi-Fei Wang, Li-Dong Cao |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2023-01-01
|
Series: | Frontiers in Immunology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fimmu.2023.1083069/full |
Similar Items
-
The interaction between intratumoral bacteria and metabolic distortion in hepatocellular carcinoma
by: Chen Xue, et al.
Published: (2024-03-01) -
Hapten-enhanced overall survival time in advanced hepatocellular carcinoma by ultro-minimum incision personalized intratumoral chemoimmunotherapy
by: Gao F, et al.
Published: (2015-06-01) -
Intratumoral Heterogeneity in Differentiated Thyroid Tumors: An Intriguing Reappraisal in the Era of Personalized Medicine
by: Antonio Ieni, et al.
Published: (2021-04-01) -
CpG Site-Specific Methylation-Modulated Divergent Expression of PRSS3 Transcript Variants Facilitates Nongenetic Intratumor Heterogeneity in Human Hepatocellular Carcinoma
by: Shuye Lin, et al.
Published: (2022-04-01) -
Intratumor Heterogeneity in Hepatocellular Carcinoma: Challenges and Opportunities
by: Sharanya Maanasi Kalasekar, et al.
Published: (2021-11-01)